Published online Jun 28, 2021. doi: 10.13105/wjma.v9.i3.220
Peer-review started: January 25, 2021
First decision: April 19, 2021
Revised: May 7, 2021
Accepted: June 4, 2021
Article in press: June 4, 2021
Published online: June 28, 2021
Processing time: 168 Days and 0.2 Hours
Coronavirus disease 2019 is a pandemic, which has affected millions of people across the globe in the year 2020. This disease is caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that belongs to the family of coronaviruses and primarily affects the respiratory system. This infection has a wide spectrum of clinical manifestations ranging from asymptomatic form to mild, moderate and severe forms depending upon the age, comorbidity and immunity of an affected individual. Hyper-inflammatory response due to SARS-CoV-2 adversely affect several internal organs. Besides lung injury, which is the main outcome of SARS-CoV-2 infection, it has been reported to adversely impact other organs including the liver and kidneys. SARS-CoV-2 virus can also have a direct adverse impact on liver as well as kidneys due to systemic inflammatory response or drug toxicity, leading to elevated levels of liver injury markers and acute kidney injury. Clinical outcomes of SARS-CoV-2 infection could be worse in patients suffering from pre-existing liver and kidney disease. So far, there have been several reports on the mechanism of liver and kidney injury during SARS-CoV-2 viral attack. However, the long-term impact of this infection on these organs is yet to be understood. This review summarizes the possible causes and effects of SARS-CoV-2 on the liver and kidneys during the infection and post recovery based on available literature.
Core Tip: Coronavirus disease 2019 (COVID-19) infected patients with pre-existing liver and kidney comorbidities are likely to have a poorer clinical prognosis and are at higher risk of severe infection and increased mortality. Data indicates that COVID-19 infection causes acute kidney and liver damage. However, its long-term consequences are yet to be elucidated. Currently in the absence of specific therapy for this viral infection, further clinical studies are needed to understand COVID-19 pathology associated with liver and kidneys. The present review summarizes the effects of COVID-19 on the liver and kidneys during infection and post recovery.